Alpha Centric Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Alpha Centric Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 25, 2022	SELL	$543.48 - $670.97 $217,392 - $268,388	-400 Closed	0 $0
Q3 2021 Mar 09, 2022	SELL	$574.03 - $680.96 $947,149 - $1.12 Million	-1,650 Reduced 80.49%	400 $242,000
Q2 2021 Mar 09, 2022	SELL	$472.8 - $558.54 $354,600 - $418,905	-750 Reduced 26.79%	2,050 $1.15 Million
Q1 2021 Mar 09, 2022	BUY	$446.73 - $548.2 $670,095 - $822,300	1,500 Added 115.38%	2,800 $1.33 Million
Q4 2020 Mar 11, 2022	BUY	$478.3 - $607.98 $564,394 - $717,416	1,180 Added 983.33%	1,300 $628,000
Q3 2020 Mar 11, 2022	BUY	$544.75 - $658.21 $65,370 - $78,985	120 New	120 $67,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.